Abstract
A validated method for the simultaneous determination of psilocin, bufotenine, lysergic acid diethylamide and its metabolites in serum, plasma and urine using liquid chromatography–electrospray ionization/tandem mass spectrometry was developed. During the solid-phase extraction procedure with polymeric mixed-mode cation exchange columns, the unstable analytes were protected by ascorbic acid, drying with nitrogen and exclusion of light. The limits of detection and quantitation for all analytes were low. Recovery was ≥86 % for all analytes and no significant matrix effects were observed. Interday and intraday imprecisions at different concentrations ranged from 1.1 to 8.2 % relative standard deviation, bias was within ±5.3 %. Processed samples were stable in the autosampler for at least 2 days. Furthermore, freeze/thaw and long-term stability were investigated. The method was successfully applied to authentic serum and urine samples.
Similar content being viewed by others
References
Horita A, Weber LJ (1961) The enzymic dephosphorylation and oxidation of psilocybin and pscilocin by mammalian tissue homogenates. Biochem Pharmacol 7:47–54
Hasler F, Bourquin D, Brenneisen R, Bär T, Vollenweider FX (1997) Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man. Pharm Acta Helv 72:175–184
Hofmann A, Heim R, Brack A, Kobel H, Frey A, Ott H, Petrzilka T, Troxler F (1959) Psilocybin und Psilocin, zwei psychotrope Wirkstoffe aus mexikanischen Rauschpilzen. Helv Chim Acta 42:1557–1572
Geschwinde T (2003) Rauschdrogen, Marktformen und Wirkungsweisen. Springer, Berlin
European Monitoring Centre for Drugs and Drug Addiction (2006) EMCDDA Thematic Papers—Hallucinogenic mushrooms: an emerging trend case study. http://www.emcdda.europa.eu/attachements.cfm/att_31215_EN_TP_Hallucinogenic_mushrooms.pdf. Accessed 13 Jul 2011
Grieshaber AF, Moore KA, Levine B (2001) The detection of psilocin in human urine. J Forensic Sci 46:627–630
Kamata T, Nishikawa M, Katagi M, Tsuchihashi H (2003) Optimized glucuronide hydrolysis for the detection of psilocin in human urine samples. J Chromatogr B 796:421–427
Kamata T, Nishikawa M, Katagi M, Tsuchihashi H (2006) Direct detection of serum psilocin glucuronide by LC/MS and LC/MS/MS: time-courses of total and free (unconjugated) psilocin concentrations in serum specimens of a “magic mushroom” user. Forensic Toxicol 24:36–40
Kärkkäinen J, Räisänen M, Huttunen MO, Kallio E, Naukkarinen H, Virkkunen M (1995) Urinary excretion of bufotenin (N,N-dimethyl-5-hydroxytryptamine) is increased in suspicious violent offenders: a confirmatory study. Psychiatry Res 58:145–152
Lyttle T, Goldstein D, Gartz J (1996) Bufo toads and bufotenine: fact and fiction surrounding an alleged psychedelic. J Psychoactive Drugs 28:267–290
Johansen SS, Jensen JL (2005) Liquid chromatography-tandem mass spectrometry determination of LSD, ISO-LSD, and the main metabolite 2-oxo-3-hydroxy-LSD in forensic samples and application in a forensic case. J Chromatogr B 825:21–28
Reuschel SA, Eades D, Foltz RL (1999) Recent advances in chromatographic and mass spectrometric methods for determination of LSD and its metabolites in physiological specimens. J Chromatogr B 733:145–159
Holzmann P (1995) Bestimmung von Psilocybin-Metaboliten im Humanplasma und -urin. Dissertation, Eberhard-Karls-Universität
Skopp G, Pötsch L, Mattern R, Aderjan R (2002) Short-term stability of lysergic acid diethylamide (LSD), N-desmethyl-LSD, and 2-oxo-3-hydroxy-LSD in urine, assessed by liquid chromatography-tandem mass spectrometry. Clin Chem 48:1615–1618
Papac DI, Foltz RL (1990) Measurement of lysergic acid diethylamide (LSD) in human plasma by gas chromatography/negative ion chemical ionization mass spectrometry. J Anal Toxicol 14:189–190
Saito K, Toyo’oka T, Fukushima T, Kato M, Shirota O, Goda Y (2004) Determination of psilocin in magic mushrooms and rat plasma by liquid chromatography with fluorimetry and electrospray ionization mass spectrometry. Anal Chim Acta 527:149–156
Björnstad K, Beck O, Helander A (2009) A multi-component LC-MS/MS method for detection of ten plant-derived psychoactive substances in urine. J Chromatogr B 877:1162–1168
Sticht G, Käferstein H (2000) Detection of psilocin in body fluids. Forensic Sci Int 113:403–407
Bogusz MJ (2000) Liquid chromatography-mass spectrometry as a routine method in forensic sciences: a proof of maturity. J Chromatogr B 748:3–19
del Mar Ramirez Fernandez M, Laloup M, Wood M, De Boeck G, Lopez-Rivadulla M, Wallemacq P, Samyn N (2007) Liquid chromatography-tandem mass spectrometry method for the simultaneous analysis of multiple hallucinogens, chlorpheniramine, ketamine, ritalinic acid, and metabolites, in urine. J Anal Toxicol 31:497–504
Elian AA, Hackett J, Telepchak MJ (2011) Analysis of psilocybin and psilocin in urine using SPE and LC-tandem mass spectrometry. LC-GC North America 29:854–859
Sklerov JH, Magluilo J, Shannon KK, Smith ML (2000) Liquid chromatography-electrospray ionization mass spectrometry for the detection of lysergide and a major metabolite, 2-oxo-3-hydroxy-LSD, in urine and blood. J Anal Toxicol 24:543–549
Bodin K, Svensson J (2001) Determination of LSD in urine with high-performance liquid chromatography-mass spectrometry. Ther Drug Monit 23:389–393
Canezin J, Cailleux A, Turcant A, Le Bouil A, Harry P, Allain P (2001) Determination of LSD and its metabolites in human biological fluids by high-performance liquid chromatography with electrospray tandem mass spectrometry. J Chromatogr B 765:15–27
Favretto D, Frison G, Maietti S, Ferrara S (2007) LC-ESI-MS/MS on an ion trap for the determination of LSD, iso-LSD, nor-LSD and 2-oxo-3-hydroxy-LSD in blood, urine and vitreous humor. Int J Legal Med 121:259–265
Chung A, Hudson J, McKay G (2009) Validated ultra-performance liquid chromatography-tandem mass spectrometry method for analyzing LSD, iso-LSD, nor-LSD, and O-H-LSD in blood and urine. J Anal Toxicol 33:253–259
Horn CK, Klette KL, Stout PR (2003) LC-MS analysis of 2-oxo-3-hydroxy LSD from urine using a Speedisk positive-pressure processor with Cerex(r) PolyChrom(tm) CLIN II Columns. J Anal Toxicol 27:459–463
Concheiro M, De Castro A, Quintela O, Cruz A, López-Rivadulla M (2007) Determination of illicit drugs and their metabolites in human urine by liquid chromatography tandem mass spectrometry including relative ion intensity criterion. J Anal Toxicol 31:573–580
Forsström J, Tuominen J, Kärkkäinen T (2001) Determination of potentially hallucinogenic N-dimethylated indoleamines in human urine by HPLC/ESI-MS-MS. Scand J Clin Lab Invest 61:547–556
Kärkkäinen J, Forsström T, Tornaeus J, Wähälä K, Kiuru P, Honkanen A, Stenman U, Turpeinen U, Hesso A (2005) Potentially hallucinogenic 5–hydroxytryptamine receptor ligands bufotenine and dimethyltryptamine in blood and tissues. Scand J Clin Lab Invest 65:189–199
Kostakis C, Byard RW (2009) Sudden death associated with intravenous injection of toad extract. Forensic Sci Int 188:e1–e5
Riceberg LJ, Vunakis HV (1978) Determination of N,N-dimethylindolealkylamines in plasma, blood and urine extracts by radioimmunoassay and high pressure liquid chromatography. J Pharmacol Exp Ther 206:158–166
Peters F, Hartung M, Herbold M, Schmitt G, Daldrup T, Mußhoff F (2009) Anhang B zur Richtlinie der GTFCh zur Qualitätssicherung bei forensisch-toxikologischen Untersuchungen: Anforderungen an die Validierung von Analysenmethoden. Toxichem Krimtech 76:185–208
Martin R, Schürenkamp J, Pfeiffer H, Köhler H (2012) A validated method for quantitation of psilocin in plasma by LC-MS/MS and study of stability. Int J Legal Med 126:845–849
Hasler F, Bourquin D, Brenneisen R, Vollenweider FX (2002) Renal excretion profiles of psilocin following oral administration of psilocybin: a controlled study in man. J Pharm Biomed Anal 30:331–339
Räisänen MJ (1984) The presence of free and conjugated bufotenin in normal human urine. Life Sci 34:2041–2045
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Martin, R., Schürenkamp, J., Gasse, A. et al. Determination of psilocin, bufotenine, LSD and its metabolites in serum, plasma and urine by SPE-LC-MS/MS. Int J Legal Med 127, 593–601 (2013). https://doi.org/10.1007/s00414-012-0796-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00414-012-0796-1